Acrodose: 5 Questions with Dr. Rachel Beddard, MD

/
Acrodose: 5 Questions with Dr. Rachel Beddard, MD

Dr. Beddard is Medical Director at South Texas Blood & Tissue Center.

"5 Questions with..." is a regular series of questions and answers with blood industry thought leaders.  This installment looks at Acrodose, an FDA-approved whole blood derived alternative to apheresis Single Donor Platelets.  Bloodbuy is not affiliated with Haemonetics, the provider of the Acrodose system, although Acrodose products are available on the Bloodbuy platform.

Read More

The Next Revolution in Blood Technology: Pathogen Reduction

/
The Next Revolution in Blood Technology: Pathogen Reduction

The blood industry has been shaken by a series of seismic shifts in recent years and the next shock is already cresting the horizon: Pathogen Reduction Technology (PRT) has the potential to transform how blood products reach patients. Other upsets have been sudden and jarring, such as 2016’s Zika epidemic and its nation-wide impact on blood availability.  In the span of a single year, an emerging pathogen was identified as a threat to the blood supply, nucleic acid tests were developed, and a new guidance was adopted by the FDA.

Read More